Global Estrogen and Progesterone Market Size, Share and Trends Analysis Report,By Type (Aglepristone, Mifepristone, Asoprisnil, Telapristone, Ulipristal Acetate), By Application (Pharmacy, Hospital, Department of Endocrinology), Forecast (2022-2028)

The global estrogen and progesterone market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Estrogen is a female reproductive hormone that plays an important role in women to promote secondary sexual characteristics such as pubic hair, breast growth. Estrogen also plays a role in mental health, cardiovascular health. Although, progesterone is a steroid hormone that is naturally produced and produced by the placenta, ovaries, etc. Progesterone plays an important role in menstruation, reproductive health, and embryogenesis. The increasing prevalence of disorders such as amenorrhea, abnormal uterine bleeding, uterine cancer are creating demand for estrogen and progesterone market.

 

An increasing number of women in brackets aged 45-59 are expected to boost the overall market growth. Synthetic progesterone is re-used as a diagnostic tool to assess the effects of estrogen due to technological advances in the medical industry. In hormone replacement therapy, it is used with estrogen. Increasing demand for hormone replacement therapy to treat post-menopausal problems among women is one of the key factors contributing to market growth. In addition, an increase in the number of adults with hormonal imbalances leads to the need for hormone replacement therapy. Additionally, increased awareness of hormone replacement therapy, especially in developing countries, is boosting the market growth. However, hormone replacement therapy has a higher risk of developing breast cancer among women, which hampers market growth in the forecast period.

 

Estrogen and progesterone are used in the treatment of female infertility. With its improved treatment therapies, the global market for estrogen and progesterone is expected to improve rapidly in the forecasted period. The global market for progesterone is driven by an increase in the spread of amenorrhea, which is anabsence of monthly periods. Looking towards, the demand for estrogen and progesterone, key market players are actively working on getting FDA approvals for their synthetic estrogen and progesterone to gain significant position in the estrogen and progesterone market. For instance, in December 2019, Drug firm Mankind Pharmalaunched its generic Dydrogesterone tablets for the treatment of infertility and pregnancy-related complications in the Indian market.

 

Further, in May 2019, Novartis announced that the company received approval for Piqray (alpelisib, formerly BYL719) the first and only treatment specifically for the treatment of postmenopausal women, and men.

 

Market Coverage

 

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

• Competitive Landscape-Bayer AG, Gedeon Richter Plc, N.V. Organon, Pfizer Inc., and Teva Pharmaceuticalsamong others.

 

Key questions addressed by the report

 

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Estrogen and Progesterone Market Report by Segment

 

By Type

• Algepristone
• Mifepristone
• Asoprisnil
• Telapristone
• Ulipristal Acetate

By Application

• Pharmacy
• Hospital
• Department of Endocrinology

 

Global Estrogen and Progesterone Market Report by Region

 

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa